Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: Mark Bartlett who wrote (8535)	1/28/2002 7:35:08 AM
From: pull_da_trigger	Read Replies (1) \| Respond to of 14101

Canadian Arthritis Bill of Rights to be launched in nation's capital TORONTO, Jan. 28 /CNW/ - There's hope for the more than 4 million Canadians living with arthritis! In a spectacular united effort that will put arthritis on the forefront of the Canadian healthcare agenda, The Arthritis Society is proud to unveil the first ever Canadian Arthritis Bill of Rights that will be presented to decision makers in Ottawa. This landmark endeavor will empower those living with arthritis to better cope with this unrelenting disease. Please join The Arthritis Society and its panel of experts on this momentous occasion. ------------------------------------------------ WHAT: MEDIA CONFERENCE WHEN: Tuesday, January 29, 2002 9:00 a.m. - 10:00 a.m. WHERE: The National Press Club Library 1 & 2 (2nd Floor) 165 Sparks St. Ottawa, ON TEL: (613) 233-5641 WHO: Mr. Denis Morrice, President, The Arthritis Society Dr. Dianne Mosher, President, The Canadian Rheumatology Association Dr. Hubert Labelle, President, The Canadian Orthopedic Foundation Helen Klassen, Patient Advocate Linda Wilhelm, Patient Advocate MODERATOR: Hazel Wood, Hazel Wood & Associates ------------------------------------------------ Interviews with speakers will follow the press conference.

To: Mark Bartlett who wrote (8535)	1/28/2002 11:06:19 AM
From: Cal Gary	Read Replies (1) \| Respond to of 14101

Mark I would think the clinical trial quarterback would be experienced knowing what is required to startup and what is expected at the completion. Assume he knows what analysis is done at the end, all checkpoints should be in place to follow protocol or process. They have to go back and review all of the patient charts (in many different centers) to ensure the trial protocols have been undertaken properly. Wouldn't there have been QA check points and audits conducted throughout the process. If its done at the end of the trials, that's scary! Say it ain't so. Bottom line -- they have to be very careful There a lot of lives and money at stake. RTQ 5.10 Nice bounce back. Dip reflects past results.